Correction: Retrospective Study on the Use of Brodalumab for Atopic Dermatitis Management: Real-World Insights

• by Nikolaos Stavropoulos, Daniel Myszkowski, Dennis Braß, Vasileios Dervenis, Effimia Poungoura, Eggert Stockfleth

• February 6, 2026

AAD Issues Pediatric Atopic Dermatitis Guidelines

Two companion guidelines provide 41 evidence-based recommendations on treatment and prevention, along with 29 statements on comorbidity associations in patients under 18

• by Kerri Miller

• April 8, 2026

• 6 min

Amendment: Dupilumab Alleviates Itching in Various Dermatological Conditions: Insights from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria

• by Gil Yosipovitch, Brian S. Kim, John Y. Koo, Zhen Chen, Simmi Wiggins, Joseph Zahn, Philip Sugerman, El-Bdaoui Haddad, Sonya L. Cyr

• March 18, 2026

AD Not Linked to Early CV Risk Markers

Repeated assessments from childhood to early adulthood did not identify consistent cardiometabolic risk patterns by disease activity or severity.

• by Kathryn Wighton

• May 27, 2026

• 5 min